210 related articles for article (PubMed ID: 32574595)
41. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node-negative non-small cell lung cancer.
Takahashi Y; Suzuki S; Matsutani N; Kawamura M
Thorac Cancer; 2019 Mar; 10(3):413-420. PubMed ID: 30666803
[TBL] [Abstract][Full Text] [Related]
42. Screening-detected lung cancers: is systematic nodal dissection always essential?
Veronesi G; Maisonneuve P; Pelosi G; Casiraghi M; Agoglia BG; Borri A; Travaini LL; Bellomi M; Rampinelli C; Brambilla D; Bertolotti R; Spaggiari L
J Thorac Oncol; 2011 Mar; 6(3):525-30. PubMed ID: 21289523
[TBL] [Abstract][Full Text] [Related]
43. Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
Miao H; Shaolei L; Nan L; Yumei L; Shanyuan Z; Fangliang L; Yue Y
Thorac Cancer; 2019 Jun; 10(6):1453-1460. PubMed ID: 31127706
[TBL] [Abstract][Full Text] [Related]
44. Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?
Doddoli C; Aragon A; Barlesi F; Chetaille B; Robitail S; Giudicelli R; Fuentes P; Thomas P
Eur J Cardiothorac Surg; 2005 Apr; 27(4):680-5. PubMed ID: 15784374
[TBL] [Abstract][Full Text] [Related]
45. Mediastinal lymph node dissection in early-stage non-small cell lung cancer: totally thoracoscopic vs thoracotomy.
Ramos R; Girard P; Masuet C; Validire P; Gossot D
Eur J Cardiothorac Surg; 2012 Jun; 41(6):1342-8; discussion 1348. PubMed ID: 22228841
[TBL] [Abstract][Full Text] [Related]
46. [Principles and results of systematic lymph node dissection in surgically treated bronchial carcinoma].
Schirren J; Richter W; Schneider P; Vogt-Moykopf I
Chirurg; 1996 Sep; 67(9):869-76. PubMed ID: 8991767
[TBL] [Abstract][Full Text] [Related]
47. Utility of mediastinoscopy in clinical stage I lung cancers at risk for occult mediastinal nodal metastases.
Fernandez FG; Kozower BD; Crabtree TD; Force SD; Lau C; Pickens A; Krupnick AS; Veeramachaneni N; Patterson GA; Jones DR; Meyers BF
J Thorac Cardiovasc Surg; 2015 Jan; 149(1):35-41, 42.e1. PubMed ID: 25439769
[TBL] [Abstract][Full Text] [Related]
48. Surgical treatment of non-small cell lung cancer: mediastinal lymph node dissection.
Meacci E; Margaritora S; Cesario A; Porziella V; Kawamukai K; Piraino A; Vita ML; Tessitore A; Cusumano G; Granone P
Rays; 2004; 29(4):423-9. PubMed ID: 15852730
[TBL] [Abstract][Full Text] [Related]
49. Current status of mediastinal lymph node dissection versus sampling in non-small cell lung cancer.
Darling GE
Thorac Surg Clin; 2013 Aug; 23(3):349-56. PubMed ID: 23931018
[TBL] [Abstract][Full Text] [Related]
50. Pre- and intra-operative mediastinal staging in non-small-cell lung cancer.
Lardinois D
Swiss Med Wkly; 2011; 141():w13168. PubMed ID: 21384283
[TBL] [Abstract][Full Text] [Related]
51. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
[TBL] [Abstract][Full Text] [Related]
52. Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer?
David EA; Cooke DT; Chen Y; Nijar K; Canter RJ; Cress RD
Ann Thorac Surg; 2017 Jan; 103(1):226-235. PubMed ID: 27469339
[TBL] [Abstract][Full Text] [Related]
53. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
[TBL] [Abstract][Full Text] [Related]
54. Comparison of clinical with pathological nodal staging from systematic mediastinal lymph node dissection in early resectable non-small cell lung cancer.
Chong CF; Khoo KL; Lim TK; Chang AY; Lim HL; Lee CN; Wong PS
Singapore Med J; 2007 Jul; 48(7):620-4. PubMed ID: 17609822
[TBL] [Abstract][Full Text] [Related]
55. Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer.
Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
Clin Lung Cancer; 2021 Mar; 22(2):120-126.e3. PubMed ID: 33485802
[TBL] [Abstract][Full Text] [Related]
56. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
[TBL] [Abstract][Full Text] [Related]
57. Mediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: a systematic review and meta-analysis.
Huang X; Wang J; Chen Q; Jiang J
PLoS One; 2014; 9(10):e109979. PubMed ID: 25296033
[TBL] [Abstract][Full Text] [Related]
58. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
[TBL] [Abstract][Full Text] [Related]
59. Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-small-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection.
Matsumura Y; Hishida T; Yoshida J; Aokage K; Ishii G; Nagai K
J Thorac Oncol; 2012 Nov; 7(11):1691-7. PubMed ID: 23059781
[TBL] [Abstract][Full Text] [Related]
60. Systemic mediastinal lymph node dissection of right lung cancer: surgical quality control and analysis of mediastinal lymph node metastatic patterns.
Wu N; Lv C; Yan S; Duan H; Zheng Q; Wang J; Xiong H; Yang Y
Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):240-3. PubMed ID: 18077504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
